{"id":"https://openalex.org/W4387765339","doi":"https://doi.org/10.1097/ijg.0000000000002321","title":"Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study","display_name":"Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study","publication_year":2023,"publication_date":"2023-10-17","ids":{"openalex":"https://openalex.org/W4387765339","doi":"https://doi.org/10.1097/ijg.0000000000002321","pmid":"https://pubmed.ncbi.nlm.nih.gov/37853676","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10681282"},"language":"en","primary_location":{"id":"doi:10.1097/ijg.0000000000002321","doi":"https://doi.org/10.1097/ijg.0000000000002321","is_oa":true,"landing_page_url":"https://doi.org/10.1097/ijg.0000000000002321","pdf_url":null,"source":{"id":"https://openalex.org/S174695746","display_name":"Journal of Glaucoma","issn_l":"1057-0829","issn":["1057-0829","1536-481X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Glaucoma","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/ijg.0000000000002321","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086048259","display_name":"Joseph F. Panarelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joseph F. Panarelli","raw_affiliation_strings":["NYU Langone Eye Center, New York, NY","NYU Langone Eye Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone Eye Center, New York, NY","institution_ids":["https://openalex.org/I4210086933"]},{"raw_affiliation_string":"NYU Langone Eye Center, New York, NY, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101529288","display_name":"Eileen C. Bowden","orcid":"https://orcid.org/0000-0002-7464-5552","observed_orcids":["https://orcid.org/0000-0002-7464-5552"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eileen C. Bowden","raw_affiliation_strings":["Department of Ophthalmology, Mitchel and Shannon Wong Eye Institute, The University of Texas at Austin, Austin, TX","Department of Ophthalmology, Mitchel and Shannon Wong Eye Institute, The University of Texas at Austin, Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Mitchel and Shannon Wong Eye Institute, The University of Texas at Austin, Austin, TX","institution_ids":["https://openalex.org/I86519309"]},{"raw_affiliation_string":"Department of Ophthalmology, Mitchel and Shannon Wong Eye Institute, The University of Texas at Austin, Austin, TX, USA","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006336605","display_name":"Michael E. Tepedino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282516798","display_name":"Atrium Health Wake Forest Baptist","ror":"https://ror.org/04v8djg66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282516798","https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E. Tepedino","raw_affiliation_strings":["Atrium Health Wake Forest Baptist, Winston-Salem, NC","Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atrium Health Wake Forest Baptist, Winston-Salem, NC","institution_ids":["https://openalex.org/I1282516798"]},{"raw_affiliation_string":"Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA","institution_ids":["https://openalex.org/I1282516798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051725756","display_name":"Noriko Odani\u2010Kawabata","orcid":"https://orcid.org/0000-0001-9776-6077","observed_orcids":["https://orcid.org/0000-0001-9776-6077"]},"institutions":[{"id":"https://openalex.org/I149737975","display_name":"Santen (Japan)","ror":"https://ror.org/032msy923","country_code":"JP","type":"company","lineage":["https://openalex.org/I149737975"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Odani-Kawabata","raw_affiliation_strings":["Santen Pharmaceutical Co., Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Santen Pharmaceutical Co., Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I149737975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024251915","display_name":"Zifan Pei","orcid":"https://orcid.org/0009-0001-6166-9678","observed_orcids":["https://orcid.org/0009-0001-6166-9678"]},"institutions":[{"id":"https://openalex.org/I4210099140","display_name":"Santen (United States)","ror":"https://ror.org/0108v8438","country_code":"US","type":"company","lineage":["https://openalex.org/I149737975","https://openalex.org/I4210099140"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zifan Pei","raw_affiliation_strings":["Santen, Inc., Emeryville, CA","Santen, Inc., Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Santen, Inc., Emeryville, CA","institution_ids":["https://openalex.org/I4210099140"]},{"raw_affiliation_string":"Santen, Inc., Emeryville, CA, USA","institution_ids":["https://openalex.org/I4210099140"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002033864","display_name":"Eugene B. McLaurin","orcid":"https://orcid.org/0000-0002-5437-5903","observed_orcids":["https://orcid.org/0000-0002-5437-5903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugene B. McLaurin","raw_affiliation_strings":["Total Eye Care, P.A., Memphis, TN","Total Eye Care, P.A., Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Total Eye Care, P.A., Memphis, TN","institution_ids":[]},{"raw_affiliation_string":"Total Eye Care, P.A., Memphis, TN, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000825873","display_name":"Auli Ropo","orcid":"https://orcid.org/0009-0009-5603-9020","observed_orcids":["https://orcid.org/0009-0009-5603-9020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Auli Ropo","raw_affiliation_strings":["Santen Oy, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Santen Oy, Helsinki, Finland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5086048259"],"corresponding_institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"],"apc_list":null,"apc_paid":null,"fwci":3.0855,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.91178449,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"32","issue":"12","first_page":"999","last_page":"1005"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-open-angle-glaucoma","display_name":"primary open-angle glaucoma","score":0.972000002861023},{"id":"https://openalex.org/keywords/ocular-hypertension","display_name":"ocular hypertension","score":1.0},{"id":"https://openalex.org/keywords/intraocular-pressure-reduction","display_name":"intraocular pressure reduction","score":0.8999999761581421},{"id":"https://openalex.org/keywords/prostaglandin-analogs","display_name":"prostaglandin analogues","score":0.7300000190734863},{"id":"https://openalex.org/keywords/glaucoma-treatment","display_name":"glaucoma treatment","score":0.4440000057220459},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6850000023841858},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.718999981880188},{"id":"https://openalex.org/keywords/washout","display_name":"washout","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.9759377241134644},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9198063611984253},{"id":"https://openalex.org/C2991803831","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Open angle glaucoma","level":3,"score":0.9120330214500427},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.7003598809242249},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.6885966658592224},{"id":"https://openalex.org/C104264131","wikidata":"https://www.wikidata.org/wiki/Q898637","display_name":"Isopropyl","level":2,"score":0.6862778663635254},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5629439353942871},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.5033225417137146},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3332177400588989},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077338","descriptor_name":"Latanoprost","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005901","descriptor_name":"Glaucoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007429","descriptor_name":"Intraocular Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/ijg.0000000000002321","doi":"https://doi.org/10.1097/ijg.0000000000002321","is_oa":true,"landing_page_url":"https://doi.org/10.1097/ijg.0000000000002321","pdf_url":null,"source":{"id":"https://openalex.org/S174695746","display_name":"Journal of Glaucoma","issn_l":"1057-0829","issn":["1057-0829","1536-481X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Glaucoma","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10681282","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10681282","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10681282/pdf/ijg-32-0999.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Glaucoma","raw_type":"Text"},{"id":"pmid:37853676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37853676","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of glaucoma","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1097/ijg.0000000000002321","doi":"https://doi.org/10.1097/ijg.0000000000002321","is_oa":true,"landing_page_url":"https://doi.org/10.1097/ijg.0000000000002321","pdf_url":null,"source":{"id":"https://openalex.org/S174695746","display_name":"Journal of Glaucoma","issn_l":"1057-0829","issn":["1057-0829","1536-481X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Glaucoma","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322516","display_name":"Santen","ror":"https://ror.org/032msy923"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387765339.pdf","grobid_xml":"https://content.openalex.org/works/W4387765339.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1977730321","https://openalex.org/W1999521109","https://openalex.org/W2066012781","https://openalex.org/W2110897487","https://openalex.org/W2130206051","https://openalex.org/W2140594570","https://openalex.org/W2827702279","https://openalex.org/W2918259642","https://openalex.org/W2954965716","https://openalex.org/W3035005545","https://openalex.org/W3036639088","https://openalex.org/W3147697734","https://openalex.org/W3189309488","https://openalex.org/W3197069414","https://openalex.org/W4200209137","https://openalex.org/W4224608775","https://openalex.org/W4240661191","https://openalex.org/W4289836823","https://openalex.org/W4293795113","https://openalex.org/W4315620084"],"related_works":["https://openalex.org/W3036639088","https://openalex.org/W3035005545","https://openalex.org/W7060747896","https://openalex.org/W2918259642","https://openalex.org/W4224608775","https://openalex.org/W2108979184","https://openalex.org/W3204571829","https://openalex.org/W4411344050","https://openalex.org/W7213223176","https://openalex.org/W4206963076"],"abstract_inverted_index":{"PR\u00c9CIS:":[0],"This":[1],"study":[2,40,69,148],"demonstrates":[3],"the":[4,44,72,155,278],"efficacy":[5,48,261],"and":[6,49,99,125,130,173,191,231,262],"safety":[7,50,249,263],"of":[8,38,51,138,167,197,201,239],"once-daily":[9],"0.002%":[10,140],"omidenepag":[11],"isopropyl":[12],"(OMDI)":[13],"in":[14,53,71,89,96,103,143,154,264,277,281],"patients":[15,112,184],"with":[16,56,267],"primary":[17,147],"open":[18],"angle":[19],"glaucoma":[20],"(POAG)":[21],"or":[22,30,58,83,86,269],"ocular":[23],"hypertension":[24],"(OHT)":[25],"who":[26],"do":[27],"not":[28],"respond":[29,31],"poorly":[32],"to":[33,42],"latanoprost.":[34],"PURPOSE:":[35],"The":[36,146,205,216],"purpose":[37],"this":[39,282],"was":[41,150,211,235],"evaluate":[43],"intraocular":[45],"pressure":[46],"(IOP)-lowering":[47],"OMDI":[52,139,232,254,260,272],"latanoprost":[54,127,228,265],"low/nonresponders":[55,266],"POAG":[57,85,268],"OHT.":[59],"MATERIALS":[60],"AND":[61],"METHODS:":[62],"Phase":[63],"3,":[64],"nonrandomized,":[65],"2-phase,":[66],"open-label,":[67],"multicenter":[68],"(NCT03697811)":[70],"United":[73],"States.":[74],"Key":[75],"inclusion":[76],"criteria":[77],"included":[78,165],"individuals":[79],"aged":[80],"18":[81],"years":[82],"above,":[84],"OHT":[87],"diagnosis":[88],"both":[90,104,144],"eyes,":[91],"IOP":[92,159,210,223],"\u226522":[93],"mm":[94,101,213,241],"Hg":[95,102,214,242],"\u22651":[97],"eye,":[98],"\u226434":[100],"eyes":[105],"at":[106,160],"all":[107],"time":[108],"points.":[109],"Overall,":[110],"107":[111],"were":[113,251],"enrolled;":[114],"104":[115],"completed":[116],"treatment.":[117,255],"Included":[118],"a":[119,131,274],"screening":[120],"period":[121,124,134,230],"(\u226435-day":[122],"washout":[123],"8-week":[126],"run-in":[128,229],"period)":[129,234],"3-month":[132,219],"treatment":[133,233,275],"comprising":[135],"one":[136],"drop":[137],"once":[141],"daily":[142],"eyes.":[145],"endpoint":[149],"changed":[151],"from":[152,225],"baseline":[153,179,208,226],"mean":[156,206,217],"diurnal":[157],"(MD)":[158],"month":[161],"3.":[162],"Safety":[163],"endpoints":[164],"incidence":[166],"adverse":[168,171,174],"events,":[169,172],"serious":[170],"drug":[175],"reactions.":[176],"RESULTS:":[177],"At":[178],"(visit":[180,220],"4),":[181],"75":[182],"(70.1%)":[183],"had":[185,189,194],"POAG,":[186],"32":[187],"(29.9%)":[188],"OHT,":[190,270],"68":[192],"(63.6%)":[193],"prior":[195],"use":[196],"prostaglandin/prostaglandin":[198],"analogs":[199],"(37.4%":[200],"whom":[202],"used":[203],"latanoprost).":[204],"(SD)":[207,218],"MD":[209,222],"23.34":[212],"(2.12).":[215],"7)":[221],"change":[224],"(following":[227],"an":[236],"additional":[237],"decrease":[238],"2.96":[240],"(2.83)":[243],"(":[244],"P":[245],"<0.0001).":[246],"No":[247],"significant":[248],"issues":[250],"reported":[252],"during":[253],"CONCLUSIONS:":[256],"These":[257],"data":[258],"demonstrate":[259],"suggesting":[271],"is":[273],"option":[276],"patient":[279],"population":[280],"study.":[283]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-10-20T00:00:00"}